We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.74%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$61.7B
AUM Growth
+$546M
(+0.89%)
Cap. Flow
-$4.01B
Cap. Flow
% of AUM
-6.5%
Top 10 Holdings %
Top 10 Hldgs %
23.47%
Holding
1,295
New
145
Increased
379
Reduced
411
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$218M |
| 2 |
Bank of America
BAC
|
+$205M |
| 3 |
Dollar General
DG
|
+$198M |
| 4 |
Union Pacific
UNP
|
+$197M |
| 5 |
Elevance Health
ELV
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$505M |
| 2 |
Rockwell Automation
ROK
|
+$373M |
| 3 |
CHL
China Mobile Limited
CHL
|
+$294M |
| 4 |
eBay
EBAY
|
+$222M |
| 5 |
TSMC
TSM
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.38% |
| 2 | Healthcare | 15.97% |
| 3 | Financials | 13.78% |
| 4 | Industrials | 11.75% |
| 5 | Communication Services | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Zions Bancorporation
ZION
$10.1B
| $3.67M | 0.01% |
79,794
-176,166
| -69% | -$8.15M |
|
552
Usana Health Sciences
USNA
$419M
| $3.67M | 0.01% |
46,189
-3,070
| -6% | -$243K |
|
553
Vanguard Morningstar Small-Cap ETF
VB
$78.9B
| $3.63M | 0.01% |
23,197
+20,897
| +909% | +$3.23M |
|
554
Celanese
CE
$4.82B
| $3.63M | 0.01% |
33,693
+33,671
| +153,050% | +$3.49M |
|
555
Petrobras Class A
PBR.A
$106B
| $3.58M | 0.01% |
252,087
+96,326
| +62% | +$1.33M |
|
556
Brinker International
EAT
$8.82B
| $3.57M | 0.01% |
90,756
+8,732
| +11% | +$359K |
|
557
Essex Property Trust
ESS
$19.1B
| $3.57M | 0.01% |
12,226
-310
| -2% | -$89.3K |
|
558
iShares Core MSCI EAFE ETF
IEFA
$186B
| $3.55M | 0.01% |
57,790
+8,180
| +16% | +$501K |
|
559
Edwards Lifesciences
EW
$49.4B
| $3.54M | 0.01% |
57,543
-12,402
| -18% | -$750K |
|
|
HQH
560
abrdn Healthcare Investors
HQH
$1.25B
| $3.54M | 0.01% |
176,100
| – | – |
|
561
Nasdaq
NDAQ
$53.4B
| $3.48M | 0.01% |
108,495
+13,971
| +15% | +$428K |
|
562
Werner Enterprises
WERN
$2.2B
| $3.48M | 0.01% |
111,817
| – | – |
|
563
Virtu Financial
VIRT
$5.04B
| $3.45M | 0.01% |
158,560
+19,423
| +14% | +$457K |
|
564
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
$4.69B
| $3.33M | 0.01% |
+112,100
| New | +$3.27M |
|
565
Exelixis
EXEL
$13.9B
| $3.29M | 0.01% |
153,830
-18,010
| -10% | -$377K |
|
566
NRG Energy
NRG
$26.2B
| $3.29M | 0.01% |
93,612
-64,905
| -41% | -$2.45M |
|
567
Equity Lifestyle Properties
ELS
$13.1B
| $3.28M | 0.01% |
54,072
-34,040
| -39% | -$2.02M |
|
568
Healthpeak Properties
DOC
$15.5B
| $3.26M | 0.01% |
101,884
+2,175
| +2% | +$67.6K |
|
569
Monster Beverage
MNST
$95.1B
| $3.25M | 0.01% |
101,972
-204,694
| -67% | -$6.17M |
|
570
Linde
LIN
$236B
| $3.25M | 0.01% |
16,195
| – | – |
|
571
Halliburton
HAL
$26.1B
| $3.22M | 0.01% |
141,766
-3,843,962
| -96% | -$99.8M |
|
572
Sprouts Farmers Market
SFM
$7.44B
| $3.22M | 0.01% |
170,597
-95,097
| -36% | -$1.98M |
|
|
MGU
573
DELISTED
Macquarie Global Infrastructure Total Return Fund, Inc.
MGU
| $3.21M | 0.01% |
135,740
-20,700
| -13% | -$470K |
|
574
Berkshire Hathaway Class A
BRK.A
$1.1T
| $3.18M | 0.01% |
10
| – | – |
|
575
ScottsMiracle-Gro
SMG
$4.09B
| $3.14M | 0.01% |
+31,860
| New | +$2.83M |
|
Similar funds
QCM
Lazard Asset Management's Q2 2019 Portfolio in Review
As of Q2 2019, Lazard Asset Management held 1,295 positions worth $61.7B, up 0.89% from $61.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $4.01B in Q2 2019, closing 104 positions and reducing 411 holdings. Its most notable exit was Utah Medical Products, an estimated $13.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Sabre worth $132M.
- Lazard Asset Management's largest Q2 2019 buy was Sabre: 5,927,264 shares worth $132M.
- Lazard Asset Management added most to Walt Disney in Q2 2019, an estimated $218M increase.
- Lazard Asset Management's biggest Q2 2019 reduction was Wells Fargo, cutting an estimated $505M.
- Lazard Asset Management fully exited Utah Medical Products in Q2 2019, selling an estimated $13.7M.
- Lazard Asset Management's ten largest holdings make up 23% of its $61.7B portfolio in Q2 2019.
- Lazard Asset Management opened 145 new positions and closed 104 in Q2 2019.
- Lazard Asset Management's portfolio value rose 0.89% quarter-over-quarter to $61.7B.
Based on Lazard Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.